GHCL
- P/E
- 8.11
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 17.40%
- Debt to Equity
- 0.02
- EPS (TTM)
- ₹50.22
- Book Value
- ₹386.13
- Market Cap
- —
- P/E (TTM)
- 8.11
- P/B
- 1.05
- ROE
- 13.00%
- Dividend Yield
- 2.98%
- EBITDA
- ₹762 Cr
- 52W High
- ₹643.45
- 52W Low
- ₹370.85
- Day Range
- ₹399.00 – ₹410.05
- Volume
- 1,51,361
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 82
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 85
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 20
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 77
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 21
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.99 times its book value
- Company has been maintaining a healthy dividend payout of 18.7%
Weaknesses
2- The company has delivered a poor sales growth of 4.23% over past five years.
- Promoter holding is low: 19.8%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 4 | 7 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Neutral | 5 | 0 | 5 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Neutral
Key readings
- RSI (14)
- 56.79
- Neutral
- MACD (12,26,9)
- −3.48
- Bullish
- SMA (50)
- 410.54
- Bearish
- SMA (200)
- 453.79
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 10Y | +1.93% |
|---|---|
| 5Y | +4.23% |
| 3Y | −12.35% |
| 1Y | −3.74% |
Net profit
| 10Y | +6.23% |
|---|---|
| 5Y | +7.68% |
| 3Y | −25.51% |
| 1Y | −24.36% |
Operating cash flow
| 10Y | +3.04% |
|---|---|
| 5Y | +2.04% |
| 3Y | −7.07% |
| 1Y | +7.68% |
Operating margin· change in pp
| 10Y | −2.33 pp |
|---|---|
| 5Y | −1.77 pp |
| 3Y | −10.51 pp |
| 1Y | −5.03 pp |
Trailing twelve months: The last four quarters end with the latest fiscal year, which the 1Y column covers.
Revenue by year
| Mar 2017 | ₹2,784 Cr |
|---|---|
| Mar 2018 | ₹2,919 Cr |
| Mar 2019 | ₹3,341 Cr |
| Mar 2020 | ₹3,305 Cr |
| Mar 2021 | ₹2,491 Cr |
| Mar 2022 | ₹3,052 Cr |
| Mar 2023 | ₹4,551 Cr |
| Mar 2024 | ₹3,447 Cr |
| Mar 2025 | ₹3,183 Cr |
| Mar 2026 | ₹3,064 Cr |
Net profit by year
| Mar 2017 | ₹380 Cr |
|---|---|
| Mar 2018 | ₹356 Cr |
| Mar 2019 | ₹351 Cr |
| Mar 2020 | ₹397 Cr |
| Mar 2021 | ₹326 Cr |
| Mar 2022 | ₹650 Cr |
| Mar 2023 | ₹1,142 Cr |
| Mar 2024 | ₹794 Cr |
| Mar 2025 | ₹624 Cr |
| Mar 2026 | ₹472 Cr |
AI Analysis — Bull vs Bear
GHCL Ltd trades at a PE of 8.6x and 1.14x book value with a market cap of Rs 4,080 crore, reflecting a nearly debt-free balance sheet but declining profitability with TTM profit down 24% and sales down 4%. The stock has corrected 26% over the past year amid weakening operating performance despite historically strong return ratios.
- Company is almost debt-free, having significantly reduced leverage, which lowers financial risk and interest burden
- Valuation appears undemanding at PE of 8.6x, well below broader market multiples for chemical sector peers
- Healthy dividend yield of 2.73% with a consistent payout ratio of 18.7%, providing income support during stock weakness
- 5-year ROE average of 21% and 10-year ROE of 21% demonstrate historically strong capital efficiency and earning power
- 5-year compounded profit growth of 7% and 10-year profit CAGR of 6% show long-term earnings have grown despite recent weakness
- 10-year stock CAGR of 7% indicates the business has created shareholder value over longer time horizons despite recent correction
- TTM compounded profit declined 24% year-over-year, signalling significant near-term earnings deterioration
- 3-year compounded profit CAGR of -25% indicates a sustained multi-year earnings decline, not just a one-off
- Sales have contracted with TTM revenue down 4% and 3-year sales CAGR of -12%, reflecting structural demand or pricing headwinds
- ROE has deteriorated from 21% (5-year average) to just 13% in the last year, a sharp drop in capital efficiency
- Promoter holding is low at 19.8%, which raises governance concerns and limits promoter alignment with minority shareholders
- Poor 5-year sales growth of only 4.23% indicates limited top-line expansion capability in the soda ash business
- Stock has declined 26% over the past year and 7% CAGR decline over 3 years, reflecting persistent negative market sentiment
- 1-year stock decline of 26% far exceeds broader market returns, suggesting company-specific challenges beyond sector weakness
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Limited recent news flow for GHCL with only a routine earnings call announcement. No identifiable headwinds or positive catalysts in the current news cycle. Investors should watch the August 3 Q1FY27 results for clarity on the company's chemical segment performance and forward guidance.
- Q1FY27 earnings call scheduled Jul 26
GHCL scheduled a conference call on August 3, 2026 at 3:00 PM IST to discuss Q1FY27 results with MD R S Jalan and CFO Raman Chopra.
Quarterly Results
₹ CrResults for the period ended Jun 2026 were due by 14 Aug 2026 and are not in this table yet.
| Particulars | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,119 | 1,019 | 805 | 797 | 823 | 830 | 793 | 779 | 781 | 796 | 721 | 757 | 791 |
| Expenses | 771 | 719 | 592 | 648 | 639 | 614 | 582 | 549 | 563 | 599 | 564 | 598 | 615 |
| Operating Profit | 349 | 299 | 213 | 150 | 184 | 217 | 211 | 230 | 218 | 197 | 157 | 159 | 176 |
| OPM % | 31% | 29% | 26% | 19% | 22% | 26% | 27% | 30% | 28% | 25% | 22% | 21% | 22% |
| Other Income | −3 | 230 | 11 | 15.58 | 17 | 18 | 17 | 29 | 23 | 27 | 17 | 16 | 14 |
| Interest | 10 | 8 | 7 | 6 | 5 | 4 | 4 | 4 | 4 | 2 | 2 | 3 | 2 |
| Depreciation | 27 | 24 | 26 | 26 | 26 | 27 | 28 | 28 | 28 | 27 | 28 | 29 | 27 |
| PBT | 309 | 497 | 191 | 133 | 170 | 203 | 196 | 227 | 209 | 195 | 145 | 143 | 160 |
| Tax % | 27% | 14% | 25% | 25% | 26% | 26% | 21% | 26% | 28% | 26% | 26% | 26% | 28% |
| Net Profit | 227 | 426 | 143 | 100 | 125 | 151 | 155 | 168 | 150 | 144 | 107 | 106 | 116 |
| EPS (₹) | 23.7 | 44.6 | 14.94 | 10.43 | 13.04 | 15.73 | 16.17 | 17.59 | 15.69 | 15 | 11.11 | 11.53 | 12.58 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,356 | 2,531 | 2,784 | 2,919 | 3,341 | 3,305 | 2,491 | 3,052 | 4,551 | 3,447 | 3,183 | 3,064 |
| Expenses | 1,828 | 1,901 | 2,103 | 2,313 | 2,582 | 2,576 | 1,886 | 2,322 | 3,048 | 2,596 | 2,306 | 2,375 |
| Operating Profit | 528 | 629 | 681 | 607 | 759 | 729 | 605 | 730 | 1,503 | 851 | 877 | 690 |
| OPM % | 22% | 25% | 24% | 21% | 23% | 22% | 24% | 24% | 33% | 25% | 28% | 22% |
| Other Income | −15 | −3 | 37 | 38 | 16 | 16 | 18 | 211 | 119 | 270 | 88 | 73 |
| Interest | 171 | 165 | 137 | 127 | 127 | 120 | 74 | 51 | 39 | 27 | 16.12 | 9.01 |
| Depreciation | 85 | 82 | 86 | 110 | 117 | 131 | 111 | 87 | 94 | 102 | 112 | 111 |
| PBT | 257 | 380 | 495 | 407 | 531 | 495 | 437 | 802 | 1,489 | 991 | 836 | 642 |
| Tax % | 29% | 32% | 23% | 13% | 34% | 20% | 25% | 19% | 23% | 20% | 25% | 26% |
| Net Profit | 182 | 258 | 380 | 356 | 351 | 397 | 326 | 650 | 1,142 | 794 | 624 | 472 |
| EPS (₹) | 18.19 | 25.78 | 38.04 | 36.59 | 35.77 | 41.75 | 34.33 | 68.14 | 119 | 82.94 | 65.18 | 51.39 |
| Div. Payout % | 12% | 0% | 13% | 14% | 14% | 7% | 16% | 22% | 15% | 14% | 18% | 23% |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 100 | 100 | 99 | 97 | 98 | 95 | 95 | 95 | 96 | 96 | 96 | 92 |
| Reserves | 670 | 936 | 1,247 | 1,513 | 1,827 | 2,054 | 2,389 | 2,852 | 3,860 | 2,883 | 3,393 | 3,460 |
| Borrowings | 1,324 | 1,365 | 1,463 | 1,322 | 1,302 | 1,254 | 782 | 788 | 361 | 210 | 119 | 83 |
| Other Liabilities | 758 | 548 | 694 | 695 | 767 | 766 | 712 | 1,261 | 816 | 581 | 578 | 665 |
| Total Liabilities | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,300 |
| Fixed Assets | 1,934 | 2,049 | 2,410 | 2,502 | 2,591 | 2,664 | 2,675 | 2,474 | 1,731 | 1,842 | 1,844 | 1,821 |
| CWIP | 7 | 37 | 26 | 74 | 117 | 122 | 81 | 213 | 109 | 55 | 256 | 450 |
| Investments | 2 | 15 | 9 | 10 | 12 | 9 | 15 | 17 | 380 | 420 | 651 | 1,042 |
| Other Assets | 909 | 848 | 1,059 | 1,043 | 1,275 | 1,375 | 1,207 | 2,292 | 2,914 | 1,453 | 1,435 | 987 |
| Total Assets | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,300 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 416 | 509 | 458 | 590 | 530 | 624 | 621 | 643 | 856 | 797 | 638 | 687 |
| Investing | −127 | −249 | −375 | −279 | −271 | −206 | −109 | −337 | −409 | −534 | −358 | −291 |
| Financing | −296 | −252 | −113 | −308 | −258 | −339 | −569 | −98 | −530 | −338 | −230 | −451 |
| Net Cash Flow | −8 | 8 | −30 | 2 | 1 | 80 | −57 | 209 | −83 | −75 | 50 | −55 |
| Free Cash Flow | 284 | 258 | 82 | 308 | 257 | 418 | 510 | 306 | 506 | 691 | 336 | 424 |
| CFO/OP | 91 | 96 | 83 | 109 | 82 | 101 | 120 | 116 | 86 | 116 | 98 | 124 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 26 | 36 | 29 | 32 | 30 | 33 | 27 | 18 | 19 | 24 | 21 |
| Inventory Days | 193 | 194 | 187 | 182 | 199 | 198 | 245 | 294 | 177 | 185 | 217 | 199 |
| Days Payable | 155 | 110 | 107 | 109 | 106 | 102 | 121 | 107 | 53 | 55 | 57 | 94 |
| Cash Conversion Cycle | 76 | 110 | 117 | 101 | 125 | 126 | 158 | 214 | 142 | 149 | 183 | 126 |
| Working Capital Days | −39 | −48 | −30 | −12 | 10 | 26 | 61 | 87 | 50 | 50 | 58 | 43 |
| ROCE % | 22% | 25% | 24% | 19% | 21% | 19% | 15% | 19% | 36% | 21% | 24% | 17% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view GHCL insights
66 extracted metrics across FY02–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- Q1 FY26 concall · Aug 2025Transcript PPT Recording
- 10 Aug 2026
- 7 Aug 2025
- 9 Sep 2024
- 6 Aug 2024
- 15 Nov 2023
Frequently Asked Questions about GHCL
What does GHCL Ltd do?
Where is GHCL Ltd (GHCL) listed?
Which sector does GHCL Ltd belong to?
What is the PE ratio of GHCL Ltd?
What is the 52-week high and low of GHCL Ltd?
Does GHCL Ltd pay dividends?
What is the Return on Equity (ROE) of GHCL Ltd?
Company Information
Established 1983, GHCL Limited is engaged in the business of manufacturing and trading of Inorganic Chemicals (Soda Ash).
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GHCL.md for GHCL Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.